Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Retrospective Case Series Study of Hypomethylating Therapy in IPSS Lower-Risk Myelodysplastic Syndrome

Han-Seung Park, MD, Je-Hwan Lee, MD, Yoo-Jin Kim, Sang Kyun Sohn, MD, PhD, Sung-Soo Yoon, Hawk Kim, June-Won Cheong, MD, Won-Sik Lee, MD, Gyeong-Won Lee, MD, Young-Don Joo, MD, Min Kyoung Kim, MD, Yang Soo Kim, MD, Hyeoung-Joon Kim

Blood (2016) 128 (22): 1992.

https://doi.org/10.1182/blood.V128.22.1992.1992

Published: 2016

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia in Remission - a Prospective Comparison of Three Different Donor Groups; Matched Sibling, Matched Unrelated, and Haploidentical Family Donors

Kyoo-Hyung Lee, MD PhD, Je-Hwan Lee, MD PhD, Jung-Hee Lee, MD PhD, Dae-Young Kim, MD PhD, Han-Seung Park, MD, Eun-Ji Choi, MD, Young-Shin Lee, MS, Young-Ah Kang, MS, Mijin Jeon, MS, Miee Seol, MS, Seung-Hyun Baek, RN, Hawk Kim, MD, Jae Hoo Park, MD, Jae-Cheol Jo, MD PhD, Yoon-Sook Choi, MD, Young-Don Joo, MD, Sung-Nam Lim, MD

Blood (2015) 126 (23): 4379.

https://doi.org/10.1182/blood.V126.23.4379.4379

Published: 2015

Journal Articles

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Je-Hwan Lee, MD PhD, Hawk Kim, MD PhD, Young-Don Joo, MD, Won Sik Lee, Sung Hwa Bae, MD, Dae Young Zang, Jihyun Kwon, MD, Min Kyoung Kim, Junglim Lee, MD, Gyeong Won Lee, Jung-Hee Lee, MD PhD, Yunsuk Choi, MD PhD, Dae-Young Kim, MD PhD, Sung-Nam Lim, MD, Sang-Min Lee, Hun-Mo Ryoo, MD, Hyo Jung Kim, Myung Soo Hyun, Kyoo-Hyung Lee, MD PhD

Blood (2015) 126 (23): 2535.

https://doi.org/10.1182/blood.V126.23.2535.2535

Published: 2015

Journal Articles

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Blood (2015) 126 (6): 746–756.

https://doi.org/10.1182/blood-2015-03-636548

Published: 2015

Includes: Supplemental data

Journal Articles

Inferior Long-Term Outcome of Front-Line Hypomethylating Agent Compared to Supportive Care in Patients with Lower Risk Myelodysplastic Syndrome: Prosensity Score Matched Analysis

Sang Kyun Sohn, MD PhD, Joon Ho Moon, MD PhD, Ahn Jae Sook, MD, PhD, Hyeoung Joon Kim, MD PhD, Moo kon Song, MD, PhD, Ho-Jin Shin, MD PhD, Won Sik Lee, MD PhD, Sang Min Lee, MD PhD, Young Don Joo, MD PhD, Ho Sup Lee, Yang Soo Kim, Yoon Young Cho, MD PhD, Sung Hwa Bae

Blood (2014) 124 (21): 3255.

https://doi.org/10.1182/blood.V124.21.3255.3255

Published: 2014

Journal Articles

Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 3654.

https://doi.org/10.1182/blood.V124.21.3654.3654

Published: 2014

Journal Articles

A Prospective Randomized Comparison of Cyclophosphamide Versus Fludarabine in Addition of Antithymocyte Globuline for Allogeneic Hematopoietic Cell Transplantation in Patients with Adult Severe Aplastic Anemia; Interim Analysis

Hawk Kim, MD, PhD., Won-Sik Lee, Yeo-Kyeoung Kim, MD PhD, Young-Don Joo, Jinny Park, MD PhD, Chul Won Jung, MD PhD, Jae-Cheol Jo, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Dae-Young Kim, MD, Kyoo-Hyung Lee, MD

Blood (2014) 124 (21): 3890.

https://doi.org/10.1182/blood.V124.21.3890.3890

Published: 2014

Journal Articles

Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload

Il hwan Kim, MD, Young Don Joo, MD PhD, Joon Ho Moon, MD PhD, Sung Nam Lim, MD, Sang Kyun Sohn, MD PhD, Gyeong Won Lee, Ho Sup Lee, Ki Young Kwon, MD PhD, Sung Hyun Kim, Kyung Tae Park, Joo Seop Chung, MD PhD, Won Sik Lee, MD PhD, Sang Min Lee, MD PhD, Myung Soo Hyun, MD PhD, Hawk Kim, Hun-Mo Ryoo, MD, Sung Hwa Bae

Blood (2014) 124 (21): 2676.

https://doi.org/10.1182/blood.V124.21.2676.2676

Published: 2014

Journal Articles

A Prospective, Multicenter Phase II Study Of Continuous Infusion Of FLAG For Patients Older Than 60 Years With Resistant Acute Myeloid Leukemia: A Comparison With Intensive Younger patients’ Trial

Hawk Kim, M.D., Je-Hwan Lee, M.D., Young-Don Joo, M.D., Sung-Hwa Bae, M.D., Ph.D., Jung-Hee Lee, Dae-Young Kim, M.D., Jae-Cheol Jo, Jae Hoo Park, Won Sik Lee, M.D., Hun-Mo Ryoo, MD, PhD, Sang-Kyu Park, Kyoo-Hyung Lee

Blood (2013) 122 (21): 3968.

https://doi.org/10.1182/blood.V122.21.3968.3968

Published: 2013

Journal Articles

Comparable Allogeneic Hematopoietic Cell Transplantation Outcome Of Haplo-Identical Family Donor With Matched Unrelated/Mismatched Family Donor In Adult Aplastic Anemia

Hawk Kim, M.D., Je-Hwan Lee, M.D., Young-Don Joo, M.D., Sung-Hwa Bae, Jung-Hee Lee, Dae-Young Kim, M.D., Jae-Cheol Jo, M.D., Jae Hoo Park, Won Sik Lee, M.D., Hun-Mo Ryoo, MD, Sang-Kyu Park, Kyoo Hyung Lee, M.D.

Blood (2013) 122 (21): 1230.

https://doi.org/10.1182/blood.V122.21.1230.1230

Published: 2013

Journal Articles

Nilotinib Combined With Multi-Agent Chemotherapy For Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Final Results Of Prospective Multicenter Phase 2 Study

Blood (2013) 122 (21): 55.

https://doi.org/10.1182/blood.V122.21.55.55

Published: 2013

Journal Articles

Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or –intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party

Blood (2012) 120 (21): 1691.

https://doi.org/10.1182/blood.V120.21.1691.1691

Published: 2012

Journal Articles

Management of Patients After the Failure of Hypomethylating Treatment for Myelodysplastic Syndrome

Je-Hwan Lee, MD, PhD, Jung-Hee Lee, Yunsuk Choi, MD, Dae-Young Kim, Kyoo-Hyung Lee, MD, Sang Min Lee, Won Sik Lee, Lee Jung-Lim, Young-Don Joo, MD, PhD

Blood (2012) 120 (21): 4953.

https://doi.org/10.1182/blood.V120.21.4953.4953

Published: 2012

Journal Articles

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia: An Interim Analysis

Je-Hwan Lee, MD, PhD, Young-Don Joo, MD, PhD, Jung-Hee Lee, Hawk Kim, MD, Sung Hwa Bae, Min Kyung Kim, MD, Dae Young Zang, Jung-Lim Lee, Gyeong Won Lee, Won Sik Lee, Jae-Hoo Park, Dae-Young Kim, Sang Min Lee, Hun Mo Ryu, Myung Soo Hyun, Hyo Jung Kim, MD, PhD, Kyoo-Hyung Lee

Blood (2012) 120 (21): 3628.

https://doi.org/10.1182/blood.V120.21.3628.3628

Published: 2012

Journal Articles

Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis.

Blood (2012) 120 (21): 3106.

https://doi.org/10.1182/blood.V120.21.3106.3106

Published: 2012

Journal Articles

Fludarabine, Cytarabine, and Attenuated-Dose Idarubicin (m-FLAI) Induction for Elderly Patients with Acute Myeloid Leukemia: Results of a Multicenter Phase II Study,

Blood (2011) 118 (21): 3626.

https://doi.org/10.1182/blood.V118.21.3626.3626

Published: 2011

Journal Articles

Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis

Blood (2011) 118 (21): 2044.

https://doi.org/10.1182/blood.V118.21.2044.2044

Published: 2011

Journal Articles

Retrospective Comparison of Azacitidine and Decitabine in the Treatment of Myleodysplastic Syndrome,

Je-Hwan Lee, MD, PhD, Sung-Doo Kim, MD, Yunsuk Choi, MD, Young-Hun Park, MD, Jae Seok Lee, MD, Dae-Young Kim, Jung-Hee Lee, Kyoo-Hyung Lee, Sang Min Lee, Won Sik Lee, Jung Lim Lee, Young-Don Joo

Blood (2011) 118 (21): 3809.

https://doi.org/10.1182/blood.V118.21.3809.3809

Published: 2011

Journal Articles

Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,

Blood (2011) 118 (21): 3424.

https://doi.org/10.1182/blood.V118.21.3424.3424

Published: 2011

Journal Articles

Hepatic Sinusoidal Obstruction Syndrome After Allogenetic Hematopoietic Stem Cell Transplantation in Adult Acquired Aplastic Anemia

Hawk Kim, Sung-Soo Yoon, Chul Won Jung, Sang Kyun Sohn, Young Don Joo, M.D., Byung Soo Kim, MD, PhD, Sung Hyun Kim, MD, PhD, Sung-Hwa Bae, MD, Ho-Jin Shin, Jong-Ho Won, Deog-Yeon Jo, MD, PhD, Jae Hoo Park, Kyoo-Hyung Lee, M.D.

Blood (2011) 118 (21): 3012.

https://doi.org/10.1182/blood.V118.21.3012.3012

Published: 2011

NARROW

Retrospective Case Series Study of Hypomethylating Therapy in IPSS Lower-Risk Myelodysplastic Syndrome

Allogeneic Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia in Remission - a Prospective Comparison of Three Different Donor Groups; Matched Sibling, Matched Unrelated, and Haploidentical Family Donors

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Inferior Long-Term Outcome of Front-Line Hypomethylating Agent Compared to Supportive Care in Patients with Lower Risk Myelodysplastic Syndrome: Prosensity Score Matched Analysis

Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

A Prospective Randomized Comparison of Cyclophosphamide Versus Fludarabine in Addition of Antithymocyte Globuline for Allogeneic Hematopoietic Cell Transplantation in Patients with Adult Severe Aplastic Anemia; Interim Analysis

Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload

A Prospective, Multicenter Phase II Study Of Continuous Infusion Of FLAG For Patients Older Than 60 Years With Resistant Acute Myeloid Leukemia: A Comparison With Intensive Younger patients’ Trial

Comparable Allogeneic Hematopoietic Cell Transplantation Outcome Of Haplo-Identical Family Donor With Matched Unrelated/Mismatched Family Donor In Adult Aplastic Anemia

Nilotinib Combined With Multi-Agent Chemotherapy For Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Final Results Of Prospective Multicenter Phase 2 Study

Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or –intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party

Management of Patients After the Failure of Hypomethylating Treatment for Myelodysplastic Syndrome

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia: An Interim Analysis

Fludarabine, Cytarabine, and Attenuated-Dose Idarubicin (m-FLAI) Induction for Elderly Patients with Acute Myeloid Leukemia: Results of a Multicenter Phase II Study,

Retrospective Comparison of Azacitidine and Decitabine in the Treatment of Myleodysplastic Syndrome,

Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,

Hepatic Sinusoidal Obstruction Syndrome After Allogenetic Hematopoietic Stem Cell Transplantation in Adult Acquired Aplastic Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only